BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1309468)

  • 1. Opioid agonists binding and responses in SH-SY5Y cells.
    Costa EM; Hoffmann BB; Loew GH
    Life Sci; 1992; 50(1):73-81. PubMed ID: 1309468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of cyclic AMP by the mu-opioid receptor in human neuroblastoma SH-SY5Y cells.
    Yu VC; Eiger S; Duan DS; Lameh J; Sadée W
    J Neurochem; 1990 Oct; 55(4):1390-6. PubMed ID: 1697894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor mechanisms of opioid tolerance in SH-SY5Y human neural cells.
    Carter BD; Medzihradsky F
    Mol Pharmacol; 1993 Mar; 43(3):465-73. PubMed ID: 8383804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.
    Traynor JR; Nahorski SR
    Mol Pharmacol; 1995 Apr; 47(4):848-54. PubMed ID: 7723747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pharmacological properties and functional coupling of mu and delta opioid receptor sites in human neuroblastoma SH-SY5Y cells.
    Kazmi SM; Mishra RK
    Mol Pharmacol; 1987 Jul; 32(1):109-18. PubMed ID: 3037297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in the expression of G-proteins and regulation of adenylate cyclase in human neuroblastoma SH-SY5Y cells chronically exposed to low-efficacy mu-opioids.
    Ammer H; Schulz R
    Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):263-71. PubMed ID: 8216227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling.
    Yabaluri N; Medzihradsky F
    Mol Pharmacol; 1997 Nov; 52(5):896-902. PubMed ID: 9351981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
    Prather PL; Tsai AW; Law PY
    J Pharmacol Exp Ther; 1994 Jul; 270(1):177-84. PubMed ID: 8035314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Go mediates the coupling of the mu opioid receptor to adenylyl cyclase in cloned neural cells and brain.
    Carter BD; Medzihradsky F
    Proc Natl Acad Sci U S A; 1993 May; 90(9):4062-6. PubMed ID: 8097884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mu-opioid-receptor-mediated inhibition of the N-type calcium-channel current.
    Seward E; Hammond C; Henderson G
    Proc Biol Sci; 1991 May; 244(1310):129-35. PubMed ID: 1679547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the mu-opioid receptors on SH-SY5Y cells using beta-funaltrexamine (beta-FNA) and naloxonazine.
    Elliott J; Smart D; Traynor JR; Lambert DG
    Biochem Soc Trans; 1993 Nov; 21(4):469S. PubMed ID: 8132037
    [No Abstract]   [Full Text] [Related]  

  • 12. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
    Van Vliet BJ; Mulder AH; Schoffelmeer AN
    J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid peptide receptor studies. 7. The methylfentanyl congener RTI-4614-4 and its four enantiomers bind to different domains of the rat mu opioid receptor.
    Lu YF; Xu H; Liu-Chen LY; Chen C; Partilla JS; Brine GA; Carroll FI; Rice KC; Lai J; Porreca F; Sadee W; Rothman RB
    Synapse; 1998 Feb; 28(2):117-24. PubMed ID: 9450512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid-inhibited adenylyl cyclase in rat brain membranes: lack of correlation with high-affinity opioid receptor binding sites.
    Nijssen PC; Sexton T; Childers SR
    J Neurochem; 1992 Dec; 59(6):2251-62. PubMed ID: 1331327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible modulation of opioid receptor binding in intact neural cells by endogenous guanosine triphosphate.
    Yabaluri N; Medzihradsky F
    Mol Pharmacol; 1995 Oct; 48(4):690-5. PubMed ID: 7476895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: I. PKC translocation to the membrane of SH-SY5Y neuroblastoma cells is induced by mu-opioid agonists.
    Kramer HK; Simon EJ
    J Neurochem; 1999 Feb; 72(2):585-93. PubMed ID: 9930730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fentanyl isothiocyanate reveals the existence of physically associated mu- and delta-opioid receptors mediating inhibition of adenylate cyclase in rat neostriatum.
    Schoffelmeer AN; Rice KC; Heijna MH; Hogenboom F; Mulder AH
    Eur J Pharmacol; 1988 Apr; 149(1-2):179-82. PubMed ID: 2840299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and chronic effects of opioids on delta and mu receptor activation of G proteins in NG108-15 and SK-N-SH cell membranes.
    Breivogel CS; Selley DE; Childers SR
    J Neurochem; 1997 Apr; 68(4):1462-72. PubMed ID: 9084416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]ohmefentanyl preferentially binds to mu-opioid receptors but also labels sigma-sites in rat brain sections.
    Wang H; Pélaprat D; Roques BP; Vanhove A; Chi ZQ; Rostène W
    Eur J Pharmacol; 1991 Feb; 193(3):341-50. PubMed ID: 1647320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerance of narcotic analgesics at the mu opioid receptor in differentiated human neuroblastoma cells.
    Yu VC; Sadée W
    J Pharmacol Exp Ther; 1988 Apr; 245(1):350-5. PubMed ID: 2834542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.